ChartMill assigns a Buy % Consensus number of 84% to KMPH. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-17 | Cantor Fitzgerald | Initiate | Overweight |
| 2022-09-15 | Canaccord Genuity | Initiate | Buy |
| 2022-08-17 | HC Wainwright & Co. | Maintains | Buy |
| 2022-01-31 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2021-04-09 | HC Wainwright & Co. | Maintains | Neutral |
| 2021-03-04 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
9 analysts have analysed KMPH and the average price target is 22.78 USD. This implies a price increase of 292.08% is expected in the next year compared to the current price of 5.81.
The consensus rating for KEMPHARM INC (KMPH) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering KEMPHARM INC (KMPH) is 9.